Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Athlone Pharmaceuticals Limited, Ballymurray, Co. Roscommon, Ireland
Ferrous Gluconate 300mg Tablets.
| Pharmaceutical Form |
|---|
|
Coated tablet. Appearance: Red, circular, biconvex, sugar-coated tablet. |
Each tablet contains 300mg ferrous gluconate.
Excipients with known effect: contains sucrose and ponceau 4R red (E124).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ferrous gluconate |
Iron is an essential constituent of the body, being necessary for haemoglobin formation and for the oxidative processes of living tissues. More than 80% of the iron present in the body is involved in the support of red blood cell production. Ferrous gluconate is indicated for the prevention and treatment of iron deficiency states. |
| List of Excipients |
|---|
|
Sodium starch glycollate Sugar-coat excipients: Sucrose |
Polypropylene tubes with high-density/low-density polyethylene caps and a silica gel desiccant. A low-density polyethylene bag contains the leaflet in the pot.
Pack sizes: 28, 100, 250,500, 1000 and 5000 tablets.
White opaque PVC 250μm and 9μm soft aluminium/35 gm 2 glassine paper child resistant foil.
Pack size: 28.
Athlone Pharmaceuticals Limited, Ballymurray, Co. Roscommon, Ireland
PL 30464/0026
Date of first authorisation: 07/08/1979
Date of last renewal: 21/09/2006
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
